Novo Nordisk’s stock tumbles as drugmaker lays out case for declining sales in 2026
The maker of Ozempic and Wegovy blamed pricing pressures and competition for its downbeat outlook. www.marketwatch.com #Novo #Nordisks #stock #tumbles…
The maker of Ozempic and Wegovy blamed pricing pressures and competition for its downbeat outlook. www.marketwatch.com #Novo #Nordisks #stock #tumbles…
Democratic senators are demanding more details on the drug pricing deals that Pfizer Inc., Eli Lilly & Co. and others…
Eli Lilly on Friday crossed the $1 trillion market-cap threshold, becoming the first drugmaker to ever reach that milestone. www.marketwatch.com…
Amgen CEO Bob Bradway detailed promising results from the company’s recent drug trial, telling CNBC’s Jim Cramer that the medicine…
Pfizer Inc. sued Metsera Inc. and rival drugmaker Novo Nordisk A/S to block the Danish company’s rival bid for the…
Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion in…
President Donald Trump on Thursday announced a deal with EMD Serono, a subsidiary of German drugmaker Merck KGaA, that aims…
AstraZeneca looks poised to announce a deal with U.S. President Donald Trump that’s focused on lowering drug prices, in a…
GSK Plc is “betting big on the US” and engaged in constructive talks on drug pricing with US President Donald…
LONDON (AP) — GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down…